Skip to content

PTC Therapeutics PTCT Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Operating margin54.2%+91.7pp-37.5%+10.0pp-47.5%+16.5pp-64%+5.5pp
Efficiency
Asset turnover0.8×+0.3×0.4×-0.1×0.5×+0.1×0.4×+0.1×
Liquidity
Current ratio2.3×0.0×2.4×+0.3×+0.3×1.7×-0.2×
Leverage
Net debt / EBITDA-0.6×
Per Share
Book value per share-$2.32+83.7%-$14.29-30.6%-$10.94-126%-$4.84-23,820%
Valuation
Market capitalization$6.1B+75.2%$3.48B+67.3%$2.08B-25.3%$2.79B-1.1%
Price / sales3.5×-0.8×4.3×+2.1×2.2×-1.8×-1.2×
EV / EBITDA5.6×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are PTC Therapeutics's profit margins?
PTC Therapeutics (PTCT) runs a 96.0% gross margin and a 1.6% operating margin, with a 42.3% net margin.
Where do PTC Therapeutics's ratios come from?
Every ratio is computed from PTC Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.